Solid
state amide hydrogen/deuterium exchange with mass spectrometric
analysis (ssHDX-MS) was used to assess the conformation of myoglobin
(Mb) in lyophilized formulations, and the results correlated with
the extent of aggregation during storage. Mb was colyophilized with
sucrose (1:1 or 1:8 w/w), mannitol (1:1 w/w), or NaCl (1:1 w/w) or
in the absence of excipients. Immediately after lyophilization, samples
of each formulation were analyzed by ssHDX-MS and Fourier transform
infrared spectroscopy (FTIR) to assess Mb conformation, and by dynamic
light scattering (DLS) and size exclusion chromatography (SEC) to
determine the extent of aggregation. The remaining samples were then
placed on stability at 25 °C and 60% RH or 40 °C and 75%
RH for up to 1 year, withdrawn at intervals, and analyzed for aggregate
content by SEC and DLS. In ssHDX-MS of samples immediately after lyophilization
(t = 0), Mb was less deuterated in solids containing
sucrose (1:1 and 1:8 w/w) than in those containing mannitol (1:1 w/w),
NaCl (1:1 w/w), or Mb alone. Deuterium uptake kinetics and peptide
mass envelopes also indicated greater Mb structural perturbation in
mannitol, NaCl, or Mb-alone samples at t = 0. The
extent of deuterium incorporation and kinetic parameters related to
rapidly and slowly exchanging amide pools (Nfast, Nslow), measured at t = 0, were highly correlated with the extent of aggregation
on storage as measured by SEC. In contrast, the extent of aggregation
was weakly correlated with FTIR band intensity and peak position measured
at t = 0. The results support the use of ssHDX-MS
as a formulation screening tool in developing lyophilized protein
drug products.